Edwards Lifesciences
1,314 hedge funds and large institutions have $43B invested in Edwards Lifesciences in 2025 Q4 according to their latest regulatory filings, with 185 funds opening new positions, 423 increasing their positions, 476 reducing their positions, and 101 closing their positions.
83% more first-time investments, than exits
New positions opened: 185 | Existing positions closed: 101
13% more capital invested
Capital invested by funds: $38.2B → $43B (+$4.81B)
5% more funds holding
Funds holding: 1,254 → 1,314 (+60)
3.21% more ownership
Funds ownership: 83.75% → 86.96% (+3.2%)
11% less repeat investments, than reductions
Existing positions increased: 423 | Existing positions reduced: 476
17% less call options, than puts
Call options by funds: $336M | Put options by funds: $407M
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$353M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$194M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$164M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$121M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$104M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$239M |
| 2 |
Holocene Advisors
New York
|
-$205M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$167M |
| 4 |
BlackRock
New York
|
-$150M |
| 5 |
Bank of New York Mellon
New York
|
-$125M |
EW Hedge Fund Activity: Q4 2025 in Review
1,314 institutional investors reported a position in Edwards Lifesciences (EW) for Q4 2025, worth a combined $43B — up 13% from $38.2B a quarter earlier.
Buyers outnumbered sellers: 185 funds opened new EW positions and 101 closed out — a net gain of 84 holders — while 423 added to existing stakes and 476 trimmed.
The largest buyer was Millennium Management, adding an estimated $353M. The largest seller was Viking Global Investors, exiting entirely with an estimated $239M sold.
- 1,314 institutional investors held Edwards Lifesciences (EW) as of Q4 2025, up from 1,254 in Q3 2025.
- Funds reported $43B of Edwards Lifesciences stock for Q4 2025, up 13% quarter-over-quarter.
- 185 funds opened new Edwards Lifesciences positions in Q4 2025 and 101 closed out, a net change of +84 holders.
- The largest Edwards Lifesciences buyer in Q4 2025 was Millennium Management, an estimated $353M added.
- The largest Edwards Lifesciences seller in Q4 2025 was Viking Global Investors, an estimated $239M sold.
Based on aggregated 13F filings for Q4 2025.